Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eyepoint Pharmaceuticals Inc (NQ: EYPT ) 9.190 +0.190 (+2.11%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 665,533 Open 9.020 Bid (Size) 9.000 (2) Ask (Size) 9.700 (3) Prev. Close 9.000 Today's Range 8.995 - 9.590 52wk Range 5.670 - 30.99 Shares Outstanding 34,984,044 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) August 13, 2024 Via Benzinga Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 12, 2024 Via Benzinga Performance YTD -59.19% -59.19% 1 Month -2.85% -2.85% 3 Month -17.43% -17.43% 6 Month -65.39% -65.39% 1 Year -18.74% -18.74% More News Read More Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday July 12, 2024 Via Benzinga Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings) May 07, 2024 Via Benzinga Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know March 08, 2024 Via Benzinga A Preview Of EyePoint Pharmaceuticals's Earnings March 06, 2024 Via Benzinga Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday May 13, 2024 Via Benzinga EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge May 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals January 22, 2024 Via Benzinga Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday May 06, 2024 Via Benzinga Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results May 06, 2024 Via Benzinga Exposures Fossil Fuels Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session May 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 06, 2024 Via Benzinga Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views May 06, 2024 Via Benzinga Topics Earnings Exposures Financial Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday? May 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 06, 2024 Via Benzinga Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying April 23, 2024 Via Benzinga EYPT Stock Earnings: EyePoint Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 March 07, 2024 Via InvestorPlace Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday March 04, 2024 Via Benzinga Topics Stocks Exposures US Equities The 3 Most Promising Stocks to Invest in Before They Take Off February 17, 2024 Via InvestorPlace 10 Health Care Stocks Whale Activity In Today's Session February 12, 2024 Via Benzinga Earnings Scheduled For March 7, 2024 March 07, 2024 Via Benzinga EyePoint Pharmaceuticals Announces Two Presentations of Topline Data with Additional Subgroup Analyses from the Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Treatment of Wet Age-Related Macular Degeneration February 03, 2024 From EyePoint Pharmaceuticals, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.